carbamates has been researched along with Vasculitis in 4 studies
Vasculitis: Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| " After a median follow-up period of 26 months (interquartile range, 20-30 mo), no patients had a serious adverse event or relapse of vasculitis." | 5.46 | Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis. ( Alric, L; Bouyer, AS; Cacoub, P; Comarmond, C; de Saint Martin, L; Ferfar, Y; Hezode, C; Musset, L; Pol, S; Poynard, T; Resche Rigon, M; Saadoun, D; Si Ahmed, SN, 2017) |
| "In patients with type 2 diabetes mellitus (T2DM), biomarkers reflecting inflammation and endothelial dysfunction have been linked to cardiovascular disease (CVD biomarkers) and metabolic regulation." | 2.73 | Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes. ( Frandsen, M; Gram, J; Lund, SS; Parving, HH; Pedersen, O; Schalkwijk, CG; Smidt, UM; Stehouwer, CD; Tarnow, L; Teerlink, T; Vaag, AA; Winther, K, 2008) |
| " After a median follow-up period of 26 months (interquartile range, 20-30 mo), no patients had a serious adverse event or relapse of vasculitis." | 1.46 | Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis. ( Alric, L; Bouyer, AS; Cacoub, P; Comarmond, C; de Saint Martin, L; Ferfar, Y; Hezode, C; Musset, L; Pol, S; Poynard, T; Resche Rigon, M; Saadoun, D; Si Ahmed, SN, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maanaoui, M | 1 |
| Saint-Jacques, C | 1 |
| Gnemmi, V | 1 |
| Frimat, M | 1 |
| Lionet, A | 1 |
| Hazzan, M | 1 |
| Noël, C | 1 |
| Provot, F | 1 |
| Comarmond, C | 2 |
| Garrido, M | 1 |
| Pol, S | 2 |
| Desbois, AC | 1 |
| Costopoulos, M | 1 |
| Le Garff-Tavernier, M | 1 |
| Si Ahmed, SN | 2 |
| Alric, L | 2 |
| Fontaine, H | 1 |
| Bellier, B | 1 |
| Maciejewski, A | 1 |
| Rosenzwajg, M | 1 |
| Klatzmann, D | 1 |
| Musset, L | 2 |
| Poynard, T | 2 |
| Cacoub, P | 2 |
| Saadoun, D | 2 |
| Ferfar, Y | 1 |
| Hezode, C | 1 |
| de Saint Martin, L | 1 |
| Bouyer, AS | 1 |
| Resche Rigon, M | 1 |
| Lund, SS | 1 |
| Tarnow, L | 1 |
| Stehouwer, CD | 1 |
| Schalkwijk, CG | 1 |
| Teerlink, T | 1 |
| Gram, J | 1 |
| Winther, K | 1 |
| Frandsen, M | 1 |
| Smidt, UM | 1 |
| Pedersen, O | 1 |
| Parving, HH | 1 |
| Vaag, AA | 1 |
1 trial available for carbamates and Vasculitis
| Article | Year |
|---|---|
Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes.
Topics: Aged; Blood Glucose; Body Weight; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabeti | 2008 |
3 other studies available for carbamates and Vasculitis
| Article | Year |
|---|---|
Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanoma: A case report.
Topics: Antineoplastic Agents; Benzimidazoles; Carbamates; Female; Glomerulonephritis; Humans; Kidney; Lung | 2017 |
Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
Topics: Aged; Antiviral Agents; B-Lymphocyte Subsets; Biomarkers; Carbamates; Case-Control Studies; Cryoglob | 2017 |
Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.
Topics: Antiviral Agents; B-Lymphocytes; Carbamates; CD4-Positive T-Lymphocytes; Cryoglobulinemia; Cryoglobu | 2017 |